Botanix Pharmaceuticals reports $10.1M quarterly net revenue
Botanix Pharmaceuticals (ASX:BOT) generated $10.1 million in net revenue for the fourth quarter of fiscal 2026.
Botanix Pharmaceuticals (ASX:BOT) generated $10.1 million in net revenue for the fourth quarter of fiscal 2026.
Bank Indonesia Governor Perry Warjiyo suddenly resigned for unspecified "personal reasons," unnerving investors who had viewed the central banker as a stabilizing force. Bloomberg's Ben Otto and Andre de Silva, plus Javelin Wealth Management Partner Polka Mishra discuss.
MS Hwang, Research Director at Counterpoint, says CXMT has been growing "much better than expected" despite lagging technological capabilities compared with its global peers. He discussed this on "Bloomberg: The China Show" after the Chinese memory chipmaker opened more than 470 percent higher in its Shanghai IPO.
MS Hwang, Research Director at Counterpoint, says CXMT has been growing "much better than expected" despite lagging technological capabilities compared with its global peers. He discussed this on "Bloomberg: The China Show" after the Chinese memory chipmaker opened more than 470 percent higher in its Shanghai IPO.
Kalgoorlie Gold Mining (ASX:KAL) recommenced reverse circulation drilling at the Lighthorse prospect within its Pinjin Gold Project.
Moonlight Resources (ASX:ML8) launches a maiden 2,500m RC drilling programme at the Goldfinger prospect in Queensland.
The Western Australian government granted state significant status to the $48.7 billion Browse Project from Woodside Energy (ASX:WDS).
Lion Selection Group (ASX:LSX) has committed $2 million to acquire a 6.7% stake in Arika Resources (ASX:ARI).
Imugene (ASX:IMU) CEO Leslie Chong has stepped down after nearly 11 years of service.
US President Donald Trump pauses military strikes on Iran to allow diplomatic talks regarding the Strait of Hormuz, as oil prices touch US$100 a barrel.
Verbrec (ASX:VBC) confirmed its FY26 revenue guidance of $120 million alongside new financial metrics for FY27.
Dexus (ASX:DXS) has sold three office properties in Sydney and Brisbane for $715 million, completing its $2 billion divestment target.